EyeBio
eyebiotech.comLocations
London, UK · New York, NY, USA · Mile End, London, UK
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2021
Eyebio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
Something looks off?Open jobs at EyeBio
On-site & Remote
Job function
Seniority
Salary